News | July 20, 2023
M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData
CMOs showed an increasing reluctance to take on debt in 2022
CMOs showed an increasing reluctance to take on debt in 2022
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
3D CMOS chip for connecting electroactive tissues and organoids to software
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
Subscribe To Our Newsletter & Stay Updated
